Bionnovation enters U.S. market with regenerative dentistry biomaterials

Bionnovation is launching in the United States with three biomaterials aimed at regenerative dentistry and everyday dental workflows. The move gives U.S. dentists access to allograft, xenograft and collagen membrane products designed to simplify procedures and support standardized treatment.

Why it matters: - Bionnovation’s U.S. launch adds new options for regenerative dentistry at a time when practices are looking for simpler, more affordable workflows. - The portfolio is positioned for general practitioners, not just specialists, which could broaden access to regenerative procedures in everyday dentistry. - The brand is part of the Geistlich Group, giving the launch backing from a company with long experience in oral regeneration.

What happened: - Bionnovation entered the U.S. market on Aug. 13, 2026 with a portfolio of biomaterials for regenerative dentistry. - The launch includes Bionnovation Allo, Bionnovation Oss XB and Bionnovation Gide XP. - The company says the products are intended to make regenerative care more accessible without compromising quality or safety.

The details: - Bionnovation Allo is a human allograft implant line for repairing, replacing and reconstructing bone in daily dental procedures. - Bionnovation Allo is available in multiple graft types and volume options. - Bionnovation Allo is processed using the Cancelle SP® Sterilization Process to ensure sterility. - Bionnovation Oss XB is a xenograft that preserves natural bone structure, porosity and topography through a patented purification process. - Bionnovation Oss XB is described as a biomimetic, regulatory-certified alternative to conventional xenografts. - Bionnovation Oss XB comes in small granules and multiple fill quantities. - Bionnovation Gide XP uses a thin, flexible design and Geistlich technology to support daily regenerative procedures. - The portfolio is designed to simplify surgical workflows and standardize treatments. - The products are available directly through the Bionnovation eShop and the release says the line is established in more than 20 countries.

Between the lines: - The launch signals a push into quality-oriented U.S. market segments with products framed around ease of use and economic efficiency. - Bionnovation is leaning on Geistlich Group credentials to build confidence with clinicians who want reliable outcomes and familiar regenerative tools. - The U.S. entry also extends a brand that was founded in Brazil in 1993 and has spent more than three decades building its biomaterials business.

What's next: - Bionnovation said the U.S. line is meant to appeal to general practitioners seeking accessible and economically balanced regenerative solutions. - William Weber, global director of business development, said the company is bringing solutions to the U.S. to make everyday regeneration easy and help dentists integrate regenerative procedures efficiently and reliably into daily practice. - Bionnovation’s U.S. expansion adds another step in the brand’s international growth after sales in more than 20 countries.

The bottom line: - Bionnovation is betting that U.S. dentists will want regenerative biomaterials that are easier to use, easier to standardize and positioned at a more accessible price point.